Talaris Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 18, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $100,000,000
Company Info
- Founders
- Dr. Suzanne Ildstad
- Company Description
- Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies.
- Market
- Organ transplant and autoimmune disorders
- Location
- Wellesley, MA, USA
- Coinvestors
- Blackstone Life Sciences, Longitude Capital, Qiming Venture Partners